ClinicalTrials.gg
CompletedNCT04617496Updated Jan 7, 2026Results posted

An RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD

An interventional study of Combined speech and exercise intervention and Health education in Parkinson's Disease, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 40 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
40 Years to 89 Years
Sex
All
01

Study summary

Nearly 90% of people with Parkinson's disease have speech and voice disorders that negatively impact their ability to communicate effectively in daily life. This study will test the hypothesis that a combined speech and exercise intervention will improve speech intelligibility in people with Parkinson's disease and speech impairment. This approach would offer an affordable way to continue to both instruct and encourage training by Veterans virtually indefinitely through the remote access technology. These findings may help VA clinicians provide optimal care for the many Veterans with Parkinson's disease and speech impairment.

Read the detailed description

Background/Rationale The great majority of individuals with Parkinson's disease (PD) develop speech impairments, most of which are grouped together and called hypokinetic dysarthria. Hypokinetic dysarthria is typically characterized by altered prosody (e.g., reduced loudness and pitch variation), phonation (e.g., breathy or harsh voice), and articulation (e.g., imprecise consonants, centralized vowels). Changes in speech may appear early in PD and progress in severity over time. Further, such changes in speech lead to significant declines in functional communication and quality of life. Pharmacological and surgical interventions that alleviate motor symptoms in PD are largely ineffective or sometimes even detrimental for speech.

Objectives Based on results from a preliminary study, the investigators propose to conduct a pilot randomized, controlled trial in patients with hypokinetic dysarthria in PD to assess the potential effectiveness of a novel home-based exercise intervention with interactive automated speech response features that encourage a higher level of speech performance. The investigators hypothesize that patients in the intervention program will improve in speech intelligibility and self-perceived communication ability over 6 months, as compared with patients in a health education program.

Methods A total of 104 community-dwelling Veterans with hypokinetic dysarthria in mild-to-moderate PD will be randomly assigned to the exercise intervention or to the health education control. The investigators will test the effects of the intervention at 6 months for the outcomes speech intelligibility and self-perceived communication ability.

02

Conditions studied

  • Parkinson's Disease

Keywords

  • Parkinson's disease
  • Dysarthria
  • Speech therapy
03

In context

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

This study's enrollment of 104 is above the median of 40 across 3,353 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,771 studies on the registry; 392 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physician diagnosis of idiopathic Parkinson's disease (PD)
  • At least 2 of the 3 cardinal signs of PD (resting tremor, rigidity, bradykinesia)
  • Response to dopaminergic medication
  • Hypokinetic dysarthria

Exclusion criteria

Exclusion Criteria:

  • Angina pectoris
  • History of myocardial infarction (MI) within 6 months
  • History of ventricular dysrhythmia requiring current therapy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
104 participants (actual)

Study arms

  • Experimental
    Combined speech and exercise intervention

    Home-based exercise intervention with interactive automated speech response features that encourage a higher level of speech performance.

    Behavioral: Combined speech and exercise intervention

  • Active comparator
    Control group

    Health education

    Behavioral: Health education

Interventions

  • BehavioralCombined speech and exercise intervention

    Home-based exercise intervention with interactive automated speech response features

  • BehavioralHealth education

    Provision of general information about a variety of topics

06

What researchers measure

Primary outcomes

  1. Change in Speech Intelligibility at 6 Months

    Speech intelligibility is the degree to which spoken language can be understood by a listener. It is measured by the percentage of words that are understood from a recording of a participant reading a random set of 11 sentences from the Assessment of Intelligibility in Dysarthric Speech Sentence Intelligibility Test stimulus bank. Native speakers of American English listened to these recordings to assess speech intelligibility. These listeners were between the ages of 18 and 35 with no history of speech, language, or hearing disorders or experience rating speech. Each listener was provided with one sentence from each study participant's recording. Listeners were asked to transcribe each sentence to the best of their ability. Their transcriptions were compared with the actual sentences to calculate the percentage of words that were understood. Possible scores range from 0 (no words understood) to 100 (all words understood). Change = (6-month score - Baseline score)

    Time frame: Baseline and 6-month Follow-up

Secondary outcomes

  1. Change in in Self-perceived Communication Ability Measured Via the Communication Effectiveness Index (CETI-M) at 6 Months

    CETI-M is a self-reported instrument assessing participants' communicative effectiveness in 10 different speaking situations (e.g., in noisy environments; over the phone) on a 10-point Likert scale, where 1 = not effective and 10 = extremely effective. Possible scores range from 10 (worst rated effectiveness) to 100 (best rated effectiveness). Change = (6-month score - Baseline score)

    Time frame: Baseline and 6-month Follow-up

07

Results

Posted Jan 7, 2026

Participant flow

Participant flow — Overall Study
MilestoneCombined Speech and Exercise InterventionControl Group
Started5054
Completed4550
Not completed54
Withdrew: Death21
Withdrew: Lost to follow-up33

Outcome measures

PrimaryChange in Speech Intelligibility at 6 Months

Speech intelligibility is the degree to which spoken language can be understood by a listener. It is measured by the percentage of words that are understood from a recording of a participant reading a random set of 11 sentences from the Assessment of Intelligibility in Dysarthric Speech Sentence Intelligibility Test stimulus bank. Native speakers of American English listened to these recordings to assess speech intelligibility. These listeners were between the ages of 18 and 35 with no history of speech, language, or hearing disorders or experience rating speech. Each listener was provided with one sentence from each study participant's recording. Listeners were asked to transcribe each sentence to the best of their ability. Their transcriptions were compared with the actual sentences to calculate the percentage of words that were understood. Possible scores range from 0 (no words understood) to 100 (all words understood). Change = (6-month score - Baseline score)

Time frame:
Baseline and 6-month Follow-up
Reported as:
Mean · score on a scale
Change in Speech Intelligibility at 6 Months
score on a scaleCombined Speech and Exercise InterventionControl Group
Change in Speech Intelligibility at 6 Months0.25 (-23.5 to 28.6)-4.78 (-45.9 to 24.4)
Statistical analysis
  • Combined Speech and Exercise Intervention vs Control Group · Mixed Models Analysis · p = 0.13 · Mean difference (net): 5.0
SecondaryChange in in Self-perceived Communication Ability Measured Via the Communication Effectiveness Index (CETI-M) at 6 Months

CETI-M is a self-reported instrument assessing participants' communicative effectiveness in 10 different speaking situations (e.g., in noisy environments; over the phone) on a 10-point Likert scale, where 1 = not effective and 10 = extremely effective. Possible scores range from 10 (worst rated effectiveness) to 100 (best rated effectiveness). Change = (6-month score - Baseline score)

Time frame:
Baseline and 6-month Follow-up
Reported as:
Mean · score on a scale
Change in in Self-perceived Communication Ability Measured Via the Communication Effectiveness Index (CETI-M) at 6 Months
score on a scaleCombined Speech and Exercise InterventionControl Group
Change in in Self-perceived Communication Ability Measured Via the Communication Effectiveness Index (CETI-M) at 6 Months6.8 (-33.1 to 57.0)-6.4 (-55.0 to 32.0)
Statistical analysis
  • Combined Speech and Exercise Intervention vs Control Group · Wilcoxon (Mann-Whitney) · p = <0.01

Adverse events

Collected over 6 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Combined Speech and Exercise Intervention2/50 (4%)0/50 (0%)0/50 (0%)
Control Group1/54 (1.9%)0/54 (0%)0/54 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Combined Speech and Exercise InterventionControl GroupTotal
Mean76.5 ± 5.573.5 ± 6.574.9 ± 6.2
Sex: Female, Male
Sex: Female, Male(Participants)Combined Speech and Exercise InterventionControl GroupTotal
Female000
Male5054104
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Combined Speech and Exercise InterventionControl GroupTotal
Race/Ethnicity — White, Non-Hispanic5053103
Race/Ethnicity — Black011
Speech Intelligibility
Speech Intelligibility(units on a scale)Combined Speech and Exercise InterventionControl GroupTotal
Mean48.7 ± 23.046.5 ± 18.447.7 ± 20.8
Communication Effectiveness Score
Communication Effectiveness Score(units on a scale)Combined Speech and Exercise InterventionControl GroupTotal
Mean50.6 ± 18.257.5 ± 14.154.2 ± 16.5
08

Study locations

1 site
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130-4817, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04617496
Responsible party
Sponsor
First posted
Nov 5, 2020
Start date
Jul 1, 2021
Primary completion
Nov 30, 2024
Completion
Apr 30, 2025
Results posted
Jan 7, 2026
Last update
Jan 7, 2026

Study contacts

David W Sparrow, DSc
principal investigator · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion